Edition:
United States

Profile: Elekta AB (publ) (EKTAb.ST)

EKTAb.ST on Stockholm Stock Exchange

72.10SEK
17 Nov 2017
Change (% chg)

-1.15kr (-1.57%)
Prev Close
73.25kr
Open
73.40kr
Day's High
73.85kr
Day's Low
71.80kr
Volume
1,040,546
Avg. Vol
1,381,806
52-wk High
95.90kr
52-wk Low
66.90kr

Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).

Company Address

Elekta AB (publ)

Kungstensgatan 18
STOCKHOLM     113 57
P: +468.58725400
F: +468.58725500

Company Web Links